L-ORNITHINE L-ASPARTATE 150mg. IP + PANCREATIN 100mg. IP

This fixed-dose combination is commonly prescribed in conditions where liver impairment is accompanied by gastrointestinal disturbances or pancreatic insufficiency. Enhances hepatic function and promotes the regeneration of liver cells. Works synergistically in managing hepatic dysfunction associated with impaired digestion and nutrient malabsorption. Supports hepatic detoxification by promoting ammonia conversion into urea and glutamine. (Claudia Isabel Blanco Vela, 2011) Aids in the management of hepatic encephalopathy and hyperammonemia. Helps reduce abdominal bloating, indigestion, and flatulence associated with impaired liver and pancreatic function. A promising option that effectively reduces ammonia levels in individuals with cirrhosis and associated hepatic encephalopathy. (Ee Teng Goh, 2018) An appropriate choice for the management and treatment of hepatic encephalopathy in cirrhosis. (McPhail, 2019) Significantly lowers blood ammonia levels and alleviates the severity of hepatic encephalopathy. (Claudia Isabel Blanco Vela, 2011) An effective strategy to lower ammonia levels is employed in the management and treatment of hepatic encephalopathy. (Gerald Kircheis, 2019) A valuable therapeutic agent for hepatic encephalopathy management that improves patients' quality of life. (Claudia Isabel Blanco Vela, 2011)